Filing Details

Accession Number:
0001181431-13-062018
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-09 19:10:07
Reporting Period:
2013-12-05
Filing Date:
2013-12-09
Accepted Time:
2013-12-09 19:10:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492426 Horizon Pharma Inc. HZNP Pharmaceutical Preparations (2834) 272179987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1523672 N Todd Smith C/O Horizon Pharma, Inc.
520 Lake Cook Road, Suite 520
Deerfield IL 60015
Evp & Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-05 18,037 $0.00 48,933 No 4 A Direct
Common Stock Acquisiton 2013-12-09 3,350 $0.00 52,283 No 4 M Direct
Common Stock Disposition 2013-12-09 1,322 $6.79 50,961 No 4 S Direct
Common Stock Disposition 2013-12-09 10,000 $6.93 40,961 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted stock units Disposition 2013-12-09 3,350 $0.00 10,048 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,698 No 4 M Direct
Footnotes
  1. Fully vested deferred issuance of restricted stock units provided as a one-time bonus payment in connection with the completion of the Company's acquisition of U.S. rights to VIMOVO (R).
  2. Includes 8,326 shares of the Company's common stock acquired in June 2013 and December 2013 pursuant to an employee stock purchase program.
  3. Reflects shares of common stock surrendered via open market sale to satisfy tax withholding obligations in connection with vesting of a restricted stock unit and the receipt of a fully vested deferred issuance stock award.
  4. Each restricted stock units represents a contingent right to receive one share of Horizon Pharma, Inc. common stock.
  5. On December 8, 2011, the reporting person was granted 13,397 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.